The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Usefulness of four commonly used neuropathic pain screening questionnaires in patients with chronic low back pain: a cross-sectional study

  • Gudala, Kapil (Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research) ;
  • Ghai, Babita (Department of Anesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research) ;
  • Bansal, Dipika (Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research)
  • Received : 2016.10.26
  • Accepted : 2016.12.23
  • Published : 2017.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Recently symptoms-based screening questionnaires have gained attention for screening for a neuropathic pain component (NePC) in various chronic pain conditions. The present study assessed the usefulness of four commonly used NePC screening questionnaires including the Self-completed douleur neuropathique 4 (S-DN4), the ID Pain, the painDETECT questionnaire (PDQ), and the Self-completed Leeds Assessment of neuropathic Symptoms and Signs (S-LANSS) questionnaire in patients with chronic low back pain (CLBP) to assess the presence of NePC. Methods: This is a single-center cross-sectional study where patients with CLBP, with or without leg pain, were included. Participants were initially screened for NePC presence by a physician according to the regular practice, and later assessed using screening questionnaires. The diagnostic accuracy of these questionnaires was compared assuming the physician-made diagnosis as the gold standard. Results: A total of 215 patients with CLBP of which 164 (76.3%, 95% CI, 70.2-81.5) had a NePC were included. S-DN4, ID Pain, and PDQ have an area under the curve (AUC) > 0.8 indicating excellent discrimination. However, S-LANSS has an AUC of 0.69 (0.62-0.75), indicating low discrimination. S-DN4 has a significantly higher AUC as compared to ID Pain (d(AUC) = 0.063, P < 0.01) and S-LANSS (d(AUC) = 0.197, P < 0.01). But the AUC of S-DN4 does not significantly differ from that of PDQ (d(AUC) = 0.013, P = 0.62). Conclusions: S-DN4, ID Pain, and PDQ, but not S-LANSS, have good discriminant validity to screen for NePCs in patients with CLBP. Despite using all the tests, 20-30% of patients with an NePC were missed. Thus, these questionnaires can only be used as an initial clue in screening for NePCs, but do not replace clinical judgment.

Keywords

References

  1. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-5. https://doi.org/10.1212/01.wnl.0000282763.29778.59
  2. Hiyama A, Watanabe M, Katoh H, Sato M, Sakai D, Mochida J. Evaluation of quality of life and neuropathic pain in patients with low back pain using the Japanese Orthopedic Association Back Pain Evaluation Questionnaire. Eur Spine J 2015; 24: 503-12. https://doi.org/10.1007/s00586-014-3723-y
  3. Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, Bouhassira D, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain 2016; 157: 1599-606. https://doi.org/10.1097/j.pain.0000000000000492
  4. Jespersen A, Amris K, Bliddal H, Andersen S, Lavik B, Janssen H, et al. Is neuropathic pain underdiagnosed in musculoskeletal pain conditions? The Danish PainDETECTive study. Curr Med Res Opin 2010; 26: 2041-5. https://doi.org/10.1185/03007995.2010.502748
  5. Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911-20. https://doi.org/10.1185/030079906X132488
  6. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the neuropathic pain symptom inventory. Pain 2004; 108: 248-57. https://doi.org/10.1016/j.pain.2003.12.024
  7. Bennett M. The LANSS pain scale: the leeds assessment of neuropathic symptoms and signs. Pain 2001; 92: 147-57. https://doi.org/10.1016/S0304-3959(00)00482-6
  8. Portenoy R. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 2006; 22: 1555-65. https://doi.org/10.1185/030079906X115702
  9. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114: 29-36. https://doi.org/10.1016/j.pain.2004.12.010
  10. Scholz J, Mannion RJ, Hord DE, Griffin RS, Rawal B, Zheng H, et al. A novel tool for the assessment of pain: validation in low back pain. PLoS Med 2009; 6: e1000047. https://doi.org/10.1371/journal.pmed.1000047
  11. Unal-Cevik I, Sarioglu-Ay S, Evcik D. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. J Pain 2010; 11: 1129-35. https://doi.org/10.1016/j.jpain.2010.02.003
  12. Li J, Feng Y, Han J, Fan B, Wu D, Zhang D, et al. Linguistic adaptation, validation and comparison of 3 routinely used neuropathic pain questionnaires. Pain Physician 2012; 15: 179-86.
  13. Gudala K, Ghai B, Bansal D. Challenges in using symptoms based screening tools while assessing neuropathic pain component in patients with chronic low back pain. J Clin Diagn Res 2016; 10: UL02-3.
  14. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014; 12: 1495-9. https://doi.org/10.1016/j.ijsu.2014.07.013
  15. Spallone V, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med 2012; 29: 578-85. https://doi.org/10.1111/j.1464-5491.2011.03500.x
  16. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 2005; 6: 149-58.
  17. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45. https://doi.org/10.2307/2531595
  18. Alkan H, Ardic F, Erdogan C, Sahin F, Sarsan A, Findikoglu G. Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study. Pain Med 2013; 14: 1933-43. https://doi.org/10.1111/pme.12222
  19. Attal N, Perrot S, Fermanian J, Bouhassira D. The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 Questionnaire. J Pain 2011; 12: 1080-7. https://doi.org/10.1016/j.jpain.2011.05.006
  20. Padua L, Briani C, Truini A, Aprile I, Bouhassira D, Cruccu G, et al. Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain. Neurol Sci 2013; 34: 373-7. https://doi.org/10.1007/s10072-012-1011-3
  21. Mathieson S, Maher CG, Terwee CB, Folly de Campos T, Lin CW. Neuropathic pain screening questionnaires have limited measurement properties. A systematic review. J Clin Epidemiol 2015; 68: 957-66. https://doi.org/10.1016/j.jclinepi.2015.03.010
  22. Gauffin J, Hankama T, Kautiainen H, Hannonen P, Haanpaa M. Neuropathic pain and use of painDETECT in patients with fibromyalgia: a cohort study. BMC Neurol 2013; 13: 21. https://doi.org/10.1186/1471-2377-13-21
  23. Bouhassira D, Attal N. Diagnosis and assessment of neuropathic pain: the saga of clinical tools. Pain 2011; 152: S74-83. https://doi.org/10.1016/j.pain.2010.09.004

Cited by

  1. Prospective, Randomized Blind Effect-on-Outcome Study of Conventional vs High-Frequency Spinal Cord Stimulation in Patients with Pain and Disability Due to Failed Back Surgery Syndrome vol.18, pp.12, 2017, https://doi.org/10.1093/pm/pnx241
  2. Validity and reliability of Arabic version of the ID Pain screening questionnaire in the assessment of neuropathic pain vol.13, pp.3, 2018, https://doi.org/10.1371/journal.pone.0192307
  3. Pharmacological target therapy of neuropathic pain and patient-reported outcomes in patients with chronic low back pain in Korea vol.97, pp.35, 2018, https://doi.org/10.1097/MD.0000000000011919
  4. Pain management in new amputees: a nursing perspective vol.28, pp.10, 2017, https://doi.org/10.12968/bjon.2019.28.10.638
  5. Evaluation of the Neuropathic Component of Chronic Low Back Pain vol.35, pp.1, 2019, https://doi.org/10.1097/ajp.0000000000000653
  6. Help-seeking behavior among community-dwelling adults with chronic pain vol.3, pp.1, 2017, https://doi.org/10.1080/24740527.2019.1570095
  7. Are painDETECT scores in musculoskeletal disorders associated with duration of daily pain and time elapsed since current pain onset? vol.4, pp.3, 2017, https://doi.org/10.1097/pr9.0000000000000739
  8. Sacroiliac joint dysfunction: clinical presentations, diagnosis, treatment vol.11, pp.2, 2017, https://doi.org/10.14412/2074-2711-2019-2s-62-68
  9. Diagnostic utility of patient history, clinical examination and screening tool data to identify neuropathic pain in low back related leg pain: a systematic review and narrative synthesis vol.21, pp.1, 2017, https://doi.org/10.1186/s12891-020-03436-6
  10. Does the presence of neuropathic pain affect the outcomes of the interlaminar epidural steroid injection for cervical disc herniation? : A prospective clinical study vol.100, pp.9, 2017, https://doi.org/10.1097/md.0000000000025012
  11. Transforaminal Epidural Steroid Injection Improves Neuropathic Pain in Lumbar Radiculopathy: A Prospective, Clinical Study vol.69, pp.4, 2021, https://doi.org/10.4103/0028-3886.323894
  12. MIS-TLIF versus O-TLIF for single-level degenerative stenosis: study protocol for randomised controlled trial vol.11, pp.3, 2021, https://doi.org/10.1136/bmjopen-2020-041134